← Open Payments lookup

RON ORDONA: Open Payments

NPI 1184050171 · LINCOLN, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,242 in 14 payments from 10 companies in 2025. Trend: 2023 $918 · 2024 $1,485 · 2025 $1,242

Food & beverage: $1,242
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.3$302
Neurocrine BioSciences, Inc.2$278
Incyte Corporation1$131
AstraZeneca Pharmaceuticals LP1$123
ALK-Abello, Inc1$119
Alkermes, Inc.1$114
Otsuka America Pharmaceutical, Inc.1$60
Novo Nordisk Inc2$56
Organogenesis Inc.1$45
Otsuka Pharmaceutical Development & Commercialization, Inc.1$15

Products named: AJOVY, TEZSPIRE, VIVITROL, INGREZZA, REXULTI, CYGNUS DUAL, Ozempic, Rybelsus.

Industry payments across CA — which companies pay providers there.